SalmoGen Company was first established in 2022 to develop a St. Johns River salmon strain for commercial aquaculture production. The broodstock is being developed at the National Cold Water Marine Aquaculture Center by the U.S. Department of Agriculture (USDA) program in Maine. General manager, Nick King, shares insights about establishing a new salmon genetics company for North America and how the new company is gearing up for its first commercial sale of eggs in fall 2026.